-
1
-
-
0026681119
-
Prevalence of age-related maculopathy: The Beaver Dam Eye Study
-
Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
-
(1992)
Ophthalmology
, vol.99
, pp. 933-943
-
-
Klein, R.1
Klein, B.E.2
Linton, K.L.3
-
2
-
-
0028839002
-
The prevalence of age-related maculopathy in the Rotterdam study
-
Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995;102:205-10.
-
(1995)
Ophthalmology
, vol.102
, pp. 205-210
-
-
Vingerling, J.R.1
Dielemans, I.2
Hofman, A.3
-
4
-
-
77954720895
-
-
Technology appraisals TA 155, 2008 accessed 29 Jul 2010
-
National Institute for Clinical Excellence. Macular degeneration (age-related) - ranibizumab and pegaptanib. Technology appraisals TA 155, 2008. http://www.nice.org.uk/nicemedia/live/11700/40254/40254.pdf (accessed 29 Jul 2010).
-
Macular Degeneration (Age-related) - Ranibizumab and Pegaptanib
-
-
-
5
-
-
33749632278
-
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration
-
DOI 10.1097/01.iae.0000242842.14624.e7, PII 0000698220061000000002
-
Ferrara N, Damico L, Shams N, et al. Development of Ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006;26:859-70. (Pubitemid 44547437)
-
(2006)
Retina
, vol.26
, Issue.8
, pp. 859-870
-
-
Ferrara, N.1
Damico, L.2
Shams, N.3
Lowman, H.4
Kim, R.5
-
6
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa054481
-
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer, D.S.4
Kaiser, P.K.5
Chung, C.Y.6
Kim, R.Y.7
-
7
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa062655
-
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-44. (Pubitemid 44511558)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
Soubrane, G.4
Heier, J.S.5
Kim, R.Y.6
Sy, J.P.7
Schneider, S.8
-
8
-
-
33947403618
-
An OCT guided, variable dosing regimen with intravitreal Ranibizumab (Lucentis) for neovascular age-related macular degeneration
-
Fung AE, Lalwani GA, Rosenfeld PJ, et al. An OCT guided, variable dosing regimen with intravitreal Ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
-
(2007)
Am J Ophthalmol
, vol.143
, pp. 566-583
-
-
Fung, A.E.1
Lalwani, G.A.2
Rosenfeld, P.J.3
-
9
-
-
69249213449
-
Evaluation of injection frequency and visual acuity outcomes for Ranibizumab monotherapy in exudative age-related macular degeneration
-
Dadgostar H, Ventura AA, Chung JY, et al. Evaluation of injection frequency and visual acuity outcomes for Ranibizumab monotherapy in exudative age-related macular degeneration. Ophthalmology 2009;116:1740-7.
-
(2009)
Ophthalmology
, vol.116
, pp. 1740-1747
-
-
Dadgostar, H.1
Ventura, A.A.2
Chung, J.Y.3
-
10
-
-
68949120732
-
Results of one-year's treatment with Ranibizumab for exudative age-related macular degeneration in a clinical setting
-
Cohen SY, Dubois L, Tadayoni R, et al. Results of one-year's treatment with Ranibizumab for exudative age-related macular degeneration in a clinical setting. Am J Ophthalmol 2009;148:409-13.
-
(2009)
Am J Ophthalmol
, vol.148
, pp. 409-413
-
-
Cohen, S.Y.1
Dubois, L.2
Tadayoni, R.3
-
11
-
-
64649096877
-
Effects of Ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration
-
Rothenbuehler SP, Waeber D, Brinkman CK, et al. Effects of Ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol 2009;147:831-7.
-
(2009)
Am J Ophthalmol
, vol.147
, pp. 831-837
-
-
Rothenbuehler, S.P.1
Waeber, D.2
Brinkman, C.K.3
-
12
-
-
69049121436
-
Ranibizumab treatment for neovascular age-related macular degeneration; from randomized trials to clinical practice
-
Michalova K, Wickremasinghe SS, Tan TH, et al. Ranibizumab treatment for neovascular age-related macular degeneration; from randomized trials to clinical practice. Eye 2009;23:1633-40.
-
(2009)
Eye
, vol.23
, pp. 1633-1640
-
-
Michalova, K.1
Wickremasinghe, S.S.2
Tan, T.H.3
-
13
-
-
79952984168
-
-
European Public Assessment Report (EPAR). accessed 6 Sep 2009
-
European Public Assessment Report (EPAR). Lucentis summary for the public: EMEA/H/C/715. http://www.emea.europa.eu/humandocs/PDFs/EPAR/lucentis/H- 715-en1.pdf (accessed 6 Sep 2009).
-
Lucentis Summary for the Public: EMEA/H/C/715
-
-
-
14
-
-
32644470399
-
Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography
-
DOI 10.1001/archopht.124.2.193
-
Chan A, Duker J, Ko TH, et al. Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 2006;124:193-8. (Pubitemid 43247068)
-
(2006)
Archives of Ophthalmology
, vol.124
, Issue.2
, pp. 193-198
-
-
Chan, A.1
Duker, J.S.2
Ko, T.H.3
Fujimoto, J.G.4
Schuman, J.S.5
-
15
-
-
34748844162
-
Angiographic and optical coherence tomographic results of the MARINA Study of ranibizumab in neovascular age-related macular degeneration
-
Kaiser PK, Blodi BA, Shapiro H, et al. Angiographic and optical coherence tomographic results of the MARINA Study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-75.
-
(2007)
Ophthalmology
, vol.114
, pp. 1868-1875
-
-
Kaiser, P.K.1
Blodi, B.A.2
Shapiro, H.3
-
16
-
-
31644448419
-
Errors in retinal thickness measurements obtained by optical coherence tomography
-
DOI 10.1016/j.ophtha.2005.10.005, PII S0161642005011772
-
Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285-93. (Pubitemid 43170778)
-
(2006)
Ophthalmology
, vol.113
, Issue.2
, pp. 285-293
-
-
Sadda, S.R.1
Wu, Z.2
Walsh, A.C.3
Richine, L.4
Dougall, J.5
Cortez, R.6
LaBree, L.D.7
-
17
-
-
14744274207
-
Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: A cross sectional study
-
DOI 10.1136/bjo.2004.043364
-
Sahni J, Stanga P, Wong D, et al. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol 2005;89:316-20. (Pubitemid 40327616)
-
(2005)
British Journal of Ophthalmology
, vol.89
, Issue.3
, pp. 316-320
-
-
Sahni, J.1
Stanga, P.2
Wong, D.3
Harding, S.4
-
18
-
-
60149107965
-
Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss
-
Arias L, Armada F, Donate J, et al. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye 2009;23:326-33.
-
(2009)
Eye
, vol.23
, pp. 326-333
-
-
Arias, L.1
Armada, F.2
Donate, J.3
|